Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 29-Sep-2022 titled SPARC to provide Update on Clinical Programs and R&D Pipeline
Press Release Sep 29 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
Earlier from Sun Pharma Advanced Research
- AGM Speech 2021-22
- FY 2021-22
- Corporate Presentation
- Press Release (Revised) Dec 10 2021
- Press Release Dec 10 2021
Later from Sun Pharma Advanced Research
- Outcome of committee meeting
- Press Release Nov 09 2022
- SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures
- Press Release Nov 18 2022
- Press Release Jul 13 2023
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research